AvePoint
AVPT
14.28
-0.31
-2.12%
AvePoint
US · AVPT
#2492 by market cap
Listed 1970
14.28
-0.31
-2.12%
Live - 5344 symbols - heartbeat 291s ago
· 2026-10-08 05:00
Pre-market
14.22
-0.42%
After-hours
14.28
0.00%
Overnight
14.23
-0.35%
- Market cap
- 3.02B
- P/E (TTM)i
- 46.06
- P/Bi
- 6.92
- EPSi
- 0.15
- Div yieldi
- 0.00%
- 52W posi
- 83%
Reader sentiment
Are you bullish or bearish on AVPT?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 6.14, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 7 years
Latest year +26.93% YoY
Margins
- Gross margin
- 74.06%
- Operating margin
- 7.87%
- Net margin
- 8.30%
Key ratios & quality
- Altman Z-Scorei
- 6.14
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 116.10M | 151.53M | 191.91M | 232.34M | 271.83M | 330.48M | 419.50M |
| Gross profit | 79.70M | 111.24M | 138.91M | 166.06M | 194.37M | 247.96M | 310.70M |
| Selling & admin expenses | 86.52M | 113.42M | 160.26M | 175.77M | 173.38M | 192.09M | 225.08M |
| Research & development | 11.15M | 12.20M | 32.14M | 31.36M | 36.34M | 48.70M | 52.59M |
| Operating profit | -19.01M | -15.44M | -53.49M | -41.07M | -15.35M | 7.17M | 33.04M |
| Pretax profit | -19.56M | -15.91M | -32.79M | -33.65M | -18.61M | -24.40M | 40.50M |
| Tax | 614.00K | 1.06M | 457.00K | 5.04M | 2.89M | 4.74M | 5.38M |
| Net profit | -20.17M | -16.97M | -33.25M | -38.69M | -21.50M | -29.14M | 35.12M |
| Basic EPS | -1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.71 | -0.29 | -0.48 | -0.23 | -0.12 | -0.16 | 0.15 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 93.06M | 102.02M | 109.73M | 114.69M | 117.24M | 124.50M |
| Gross profit | 69.17M | 75.54M | 81.58M | 84.41M | 85.37M | 91.01M |
| Selling & admin expenses | 53.19M | 55.49M | 59.52M | 56.88M | 58.88M | 64.22M |
| Research & development | 12.69M | 12.96M | 13.94M | 13.00M | 13.76M | 16.56M |
| Operating profit | 3.29M | 7.09M | 8.13M | 14.53M | 12.73M | 10.22M |
| Pretax profit | 4.87M | 6.85M | 12.81M | 15.97M | 16.54M | 12.01M |
| Tax | 1.31M | 3.96M | -210.00K | 323.00K | 1.29M | -15.56M |
| Net profit | 3.57M | 2.89M | 13.02M | 15.64M | 15.25M | 27.57M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.02 | 0.01 | 0.06 | 0.07 | 0.07 | 0.12 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Total current assets | -- | 120.70M | 334.16M | 306.30M | 325.58M | 394.80M | 625.31M |
| Cash & ST investments | -- | 70.10M | 270.63M | 229.81M | 226.88M | 290.74M | 481.06M |
| Inventory | -- | -- | -- | -- | -- | -- | -- |
| Total assets | -- | 169.05M | 388.74M | 415.53M | 442.58M | 519.06M | 789.18M |
| Total current liabilities | -- | 92.22M | 111.18M | 142.71M | 176.67M | 222.96M | 273.69M |
| Short-term debt | -- | -- | -- | 5.39M | 5.34M | -- | -- |
| Long-term debt | -- | -- | -- | -- | -- | -- | -- |
| Total liabilities | -- | 148,867,000.00 | 133,173,000.00 | 172,379,000.00 | 217,738,000.00 | 248,107,000.00 | 310,482,000.00 |
| Total equity | -- | 20.19M | 255.57M | 243.15M | 224.84M | 270.95M | 478.70M |
| Retained earnings | -- | -299.79M | -375.30M | -416.93M | -460.50M | -510.45M | -510.08M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 446.64M | 539.82M | 580.69M | 625.31M | 562.25M | 557.49M |
| Cash & ST investments | 351.80M | 430.14M | 471.64M | 481.06M | 444.14M | 417.25M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 598.85M | 700.13M | 743.52M | 789.18M | 734.19M | 757.00M |
| Total current liabilities | 208.21M | 228.23M | 244.86M | 273.69M | 260.26M | 278.93M |
| Short-term debt | -- | -- | -- | -- | -- | -- |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 237,395,000.00 | 256,994,000.00 | 276,706,000.00 | 310,482,000.00 | 295,382,000.00 | 320,129,000.00 |
| Total equity | 361.45M | 443.14M | 466.81M | 478.70M | 438.81M | 436.87M |
| Retained earnings | -515.47M | -517.95M | -510.87M | -510.08M | -531.32M | -531.73M |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -2.05M | 19.12M | 5.03M | -774.00K | 34.69M | 88.89M | 85.26M |
| Depreciation & amortization | 1.05M | 1.06M | 1.24M | 3.49M | 4.69M | 5.38M | 6.21M |
| Free cash flow | -3.13M | 18.10M | 2.57M | -6.24M | 31.17M | 84.64M | 79.95M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 33.67M | 66.28M | -875.00K | -19.93M | -39.04M | -33.05M | -49.75M |
| Ending cash balance | 12.16M | 69.11M | 268.22M | 227.19M | 223.16M | 290.74M | 481.06M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 495.00K | 20.27M | 34.83M | 29.66M | 24.26M | 15.94M |
| Depreciation & amortization | 1.51M | 1.62M | 1.52M | 1.56M | 1.66M | 1.72M |
| Free cash flow | -1.47M | 18.95M | 33.98M | 28.50M | 22.55M | 14.20M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -11.91M | -7.05M | -8.36M | -22.44M | -59.81M | -50.52M |
| Ending cash balance | 351.48M | 429.82M | 471.64M | 481.06M | 444.14M | 417.25M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -162.08 | -17.36 | -9.88 | -12.13 | 9.31 |
| ROA %i | -- | -30.43 | -24.43 | -10.35 | -5.06 | -6.05 | 5.32 |
| ROIC %i | -- | -- | -162.26 | -16.23 | -9.23 | -11.44 | 8.03 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- | -38.43 |
| EBIT margin %i | -16.38 | -10.19 | -27.87 | -17.68 | -5.65 | 2.17 | 7.87 |
| FCF / sales %i | -- | 11.94 | 1.34 | -- | 11.47 | 25.61 | 19.06 |
| Current ratioi | -- | 1.31 | 3.01 | 2.15 | 1.84 | 1.77 | 2.28 |
| Quick ratioi | -- | 1.28 | 2.93 | 2.08 | 1.77 | 1.70 | 2.21 |
| Debt / assetsi | -- | -- | 0.00 | 4.03 | 3.33 | 1.91 | 1.26 |
| LT debt / equityi | -- | -- | -- | 4.95 | 4.46 | 3.68 | 2.08 |
| Interest coveragei | -- | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | 26.02 | 21.51 | 19.86 | 21.77 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | 19.87 | 220.58 | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -8.39 | -2.60 | 0.58 | 9.31 | 11.68 | 16.25 |
| ROA %i | -4.73 | -1.50 | 0.33 | 5.32 | 6.99 | 9.81 |
| ROIC %i | -8.11 | -2.79 | -0.23 | 8.03 | 11.32 | 15.75 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 3.91 | 6.13 | 5.93 | 7.87 | 9.57 | 9.78 |
| FCF / sales %i | 21.86 | 21.40 | 21.12 | 19.06 | 23.43 | 21.29 |
| Current ratioi | 2.15 | 2.37 | 2.37 | 2.28 | 2.16 | 2.00 |
| Quick ratioi | 2.07 | 2.29 | 2.30 | 2.21 | 2.09 | 1.92 |
| Debt / assetsi | 1.95 | 1.66 | 1.53 | 1.26 | 1.81 | 2.15 |
| LT debt / equityi | 3.24 | 2.62 | 2.43 | 2.08 | 3.02 | 3.73 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-08 05:00:35 · For reference only, not investment advice and not tailored to your situation.